State of the science: Uterine sarcomas: From pathology to practice
- PMID: 32839026
- DOI: 10.1016/j.ygyno.2020.08.008
State of the science: Uterine sarcomas: From pathology to practice
Conflict of interest statement
Declaration of Competing Interest Drs. Shushkevic, LIttell, Shah, Chiang, Thornton, Toboni. Levine, Dowdy and Klopp have nothing to disclose. Dr. Thaker reports grants and personal fees from Merck, personal fees from Stryker, personal fees from Celsion, personal fees from Astra Zeneca, grants and personal fees from GlaxoSmithKline, personal fees from Iovance, personal fees from Aravive, personal fees from Mersana, outside the submitted work. Dr. Hensley reports her spouse is an employee of Sanofi, and reports royalties from a chapter from Up To Date and honoraria from GSK and Tesaro. Dr. Slomovitz reports personal fees from Abbvie, AstraZeneca, Clovis, Genentech, GSK, Myriad, and Incyte; and research support from Novartis. Dr. Holcomb is a consultant for Johnson and Johnson and receives research support from Fujirebio Diagnostics. Neither relationship is relevant to the current manuscript. Dr. Leitao reports personal fees from JnJ/Ethicon, outside the submitted work; and Dr. Leitao is an ad hoc speaker for Intuitive Surgical, Inc. Dr. Powell reports consultant fees from Merck, Tesaro, AstraZeneca, Clovis, and Eisai, outside the submitted work. Dr. Brown reports personal fees from Clovis and GSK, outside the submitted work.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical